About prf technologies ltd - PRFX
PRF Technologies Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. It offers PRF-110, an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized and extended post-operative analgesia. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
PRFX At a Glance
PRF Technologies Ltd.
65 Yigal Alon Street
Tel Aviv, Tel Aviv 6744316
| Phone | 972-3-717-7051 | Revenue | 17.00K | |
| Industry | Pharmaceuticals: Major | Net Income | -4,838,000.00 | |
| Sector | Health Technology | Employees | 7 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
PRFX Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 122.314 |
| Price to Book Ratio | 0.312 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 0.313 |
| Enterprise Value to Sales | -77.568 |
| Total Debt to Enterprise Value | -0.016 |
PRFX Efficiency
| Revenue/Employee | 2,428.571 |
| Income Per Employee | -691,142.857 |
| Receivables Turnover | 0.12 |
| Total Asset Turnover | 0.002 |
PRFX Liquidity
| Current Ratio | 1.782 |
| Quick Ratio | 1.782 |
| Cash Ratio | 1.707 |
PRFX Profitability
| Gross Margin | -4,864.706 |
| Operating Margin | -29,335.294 |
| Pretax Margin | -29,494.118 |
| Net Margin | -28,458.824 |
| Return on Assets | -58.561 |
| Return on Equity | -93.335 |
| Return on Total Capital | -56.492 |
| Return on Invested Capital | -93.335 |
PRFX Capital Structure
| Total Debt to Total Equity | 0.246 |
| Total Debt to Total Capital | 0.245 |
| Total Debt to Total Assets | 0.175 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |